Pericardial effusion due to metastatic prostate cancer: a case report

June 13, 2008 | Comments Off on Pericardial effusion due to metastatic prostate cancer: a case report

Hinyokika Kiyo. 2008 May;54(5):369-72. [Link] Yagihashi Y, Okinami T, Fukuzawa S, Kuriki K. Shimada Municipal Hospital. Abstract We describe a patient whose complaints were related to pericardial effusion due to…

Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials

June 11, 2008 | Comments Off on Pemetrexed plus carboplatin in elderly patients with malignant pleural mesothelioma: combined analysis of two phase II trials

British Journal of Cancer. 2008 Jun 10. [Epub ahead of print] [Link] Ceresoli GL, Castagneto B, Zucali PA, Favaretto A, Mencoboni M, Grossi F, Cortinovis D, Conte GD, Ceribelli A,…

Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma

June 11, 2008 | Comments Off on Cisplatin and vinorelbine first-line chemotherapy in non-resectable malignant pleural mesothelioma

British Journal of Cancer. 2008 Jun 10. [Epub ahead of print] [Link] Sørensen JB, Frank H, Palshof T. 1Department Oncology, Finsen Centre/National University Hospital, 9 Blegdamsvej, Copenhagen DK-2100, Denmark. Abstract…

Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma

June 11, 2008 | Comments Off on Erlotinib plus bevacizumab in previously treated patients with malignant pleural mesothelioma

Cancer. 2008 Jun 9. [Epub ahead of print] [Link] Jackman DM, Kindler HL, Yeap BY, Fidias P, Salgia R, Lucca J, Morse LK, Ostler PA, Johnson BE, Jänne PA. Dana‐Farber…

Excess of Mesotheliomas after Exposure to Chrysotile in Balangero, Italy

June 6, 2008 | Comments Off on Excess of Mesotheliomas after Exposure to Chrysotile in Balangero, Italy

Occupational and Environmental Medicine. 2008 Jun 4. [Epub ahead of print] [Link] Mirabelli D, Calisti R, Barone Adesi F, Fornero E, Merletti F, Magnani C. Unit of Cancer Epidemiology, CeRMS…

Uroplakin is not a Reliable Immunohistochemical Marker for Malignant Mesothelioma of the Pleura

June 6, 2008 | Comments Off on Uroplakin is not a Reliable Immunohistochemical Marker for Malignant Mesothelioma of the Pleura

Applied immunohistochemistry & molecular morphology. 2008 Jun 3. [Epub ahead of print] [Link] Butnor KJ, Ordonez NG. *The University of Vermont, Burlington, VT †M.D. Anderson Cancer Center, Houston, TX. Abstract…

Long-term mortality from pleural and peritoneal cancer after exposure to asbestos: Possible role of asbestos clearance

June 6, 2008 | Comments Off on Long-term mortality from pleural and peritoneal cancer after exposure to asbestos: Possible role of asbestos clearance

International Journal of Cancer. 2008 Jun 4. [Epub ahead of print] [Link] Barone-Adesi F, Ferrante D, Bertolotti M, Todesco A, Mirabelli D, Terracini B, Magnani C. Unit of Cancer Epidemiology,…

Diagnostic usefulness and challenges in the diagnosis of mesothelioma by endoscopic ultrasound guided fine needle aspiration

June 6, 2008 | Comments Off on Diagnostic usefulness and challenges in the diagnosis of mesothelioma by endoscopic ultrasound guided fine needle aspiration

Diagnostic Cytopathology. 2008 Jun 4;36(7):503-507. [Epub ahead of print] [Link] Bakdounes K, Jhala N, Jhala D. Department of Pathology, University of Alabama at Birmingham, Birmingham, Alabama. Abstract Malignant mesothelioma is…

Cytomorphologic features of well-differentiated papillary mesothelioma in peritoneal effusion: A case report

June 6, 2008 | Comments Off on Cytomorphologic features of well-differentiated papillary mesothelioma in peritoneal effusion: A case report

Diagnostic Cytopathology. 2008 Jun 4;36(7):512-515. [Epub ahead of print] [Link] Ikeda K, Suzuki T, Tate G, Mitsuya T. Department of Pathology, Showa University Fujigaoka Hospital, Fujigaoka, Yokohama, Japan. Abstract Well-differentiated…

Response of a Patient with Pleural and Peritoneal Mesothelioma after Second-Line Chemotherapy with Lipoplatin and Gemcitabine

June 5, 2008 | Comments Off on Response of a Patient with Pleural and Peritoneal Mesothelioma after Second-Line Chemotherapy with Lipoplatin and Gemcitabine

Oncology. 2007;73:426-429. [Link] Karpathiou G, Argiana E, Koutsopoulos A, Froudarakis ME. Department of Pneumonology, Medical School Democritus University of Thrace, Alexandroupolis, Greece. Abstract We report the case of a 56-year-old…

Categories